Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Xenon Pharmaceuticals Reports Long-Term Efficacy and Safety Data for Azetukalner in Open-Label Extension Study at AES 2024 Quiver Quantitative, Inc. - Sat Dec 7, 1:22AM CST

Xenon Pharmaceuticals reports long-term efficacy and safety of azetukalner for focal onset seizures, showing significant seizure reduction and patient well-being.Quiver AI SummaryXenon Pharmaceuticals...

XENE : 38.63 (-0.69%)
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024 GlobeNewswire - Fri Dec 6, 3:01PM CST

XENE : 38.63 (-0.69%)
Xenon Pharmaceuticals Inc. Announces Multiple Poster Presentations at AES 2024 Featuring New Data on Azetukalner and Nav1.1 Program Quiver Quantitative, Inc. - Mon Nov 25, 5:52PM CST

Xenon Pharmaceuticals will present five posters at the AES 2024 showcasing new data on azetukalner and mental health burdens in epilepsy.Quiver AI SummaryXenon Pharmaceuticals Inc. announced that it will...

XENE : 38.63 (-0.69%)
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024 GlobeNewswire - Mon Nov 25, 7:30AM CST

XENE : 38.63 (-0.69%)
Xenon to Present at Upcoming Investor Conferences GlobeNewswire - Wed Nov 13, 3:01PM CST

XENE : 38.63 (-0.69%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot AP - Tue Nov 12, 3:07PM CST

Xenon Pharmaceuticals: Q3 Earnings Snapshot

XENE : 38.63 (-0.69%)
Xenon Reports Q3 2024 Financial Results and Business Update GlobeNewswire - Tue Nov 12, 3:01PM CST

XENE : 38.63 (-0.69%)
Xenon to Report Q3 2024 Financial Results on November 12, 2024 GlobeNewswire - Tue Nov 5, 3:01PM CST

XENE : 38.63 (-0.69%)
Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe
Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe Zacks Investment Research - Fri Oct 11, 10:30AM CDT

Intra-Cellular ITCI is focused on discovering, developing and commercializing small molecule drugs for treating neuropsychiatric and neurological disorders. The company currently has only one marketed...

ITCI : 83.45 (-0.82%)
XENE : 38.63 (-0.69%)
AXSM : 90.73 (+1.10%)
Xenon Pharmaceuticals: Q2 Earnings Snapshot AP - Thu Aug 8, 3:26PM CDT

Xenon Pharmaceuticals: Q2 Earnings Snapshot

XENE : 38.63 (-0.69%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot